Clinical Trial Update: To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 study to compare the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Sandoz | Conditions: Pain | Phase 1 | Status: COMPLETED